Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas

European Journal of Endocrinology

Volumn 146, Issue 6, 2002, Pages 759-766

  Peri, Alessandro ^a   Luciani, Paola ^a   Tonacchera, Massimo ^a   Agretti, Patrizia ^a   Baglioni Peri, Silvana ^a   Buci, Lisa ^a   Conforti, Barbara ^a   Cioppi, Federica ^a   Biliotti, Giancarlo ^a   Serio, Mario ^a   Vitti, Paolo ^a   Chiovato, Luca ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; SERINE; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID NODULE; TISSUE LEVEL; WESTERN BLOTTING;

EID: 0036307609     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460759     Document Type: Article

References (39)

1. Toxic adenoma and toxic multinodular goiter
2. The autonomously functioning thyroid nodule: Goetsch's disease
3. Two G protein oncogenes in human endocrine tumors
4. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
5. TSH receptor mutations and thyroid disease
6. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan
7. ++ cascades
8. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma
9. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms
10. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter
11. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenoma
12. Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors
13. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors
14. Transcriptional regulation by cyclic AMP-responsive factors
15. 3′, 5′-Cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line
16. Requirement for cAMP-response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture
17. Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Two distinct forms of active transcription factor CREB (cAMP response element binding protein)
20. Analysis of gene expression: Use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase
21. Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A-inhibitory protein
22. Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone-secreting tumors
23. Gonadotropin releasing hormone receptor gene expression in human ovary and granulosa-lutein cells
24. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas
25. Expression of cyclic adenosine 3′-5′-monophosphate (cAMP)-responsive element binding protein and inducible cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsα gene
26. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating TSHr mutations with solitary toxic adenoma
27. Pituitary follicle-stimulating hormone (FSH) induces CREM gene expression in Sertoli cells: Involvement in long-term desensitization of the FSH receptor
28. Gonadotropins regulate inducible cyclic adenosine 3′, 5′-monophosphate early repressor in the rat ovary: Implications for inhibin alpha subunit gene expression
29. Regulation of cAMP responsive element binding modulator isoforms in cultured rat ovarian granulosa cells
30. Increased thyroid epithelial cell proliferation in toxic thyroid nodules
31. The 3′, 5′-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas
32. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas
33. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: Effect of Gs(alpha) mutations
34. Constitutively active Gsα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas
35. Recent progress in understanding the hormonal regulation of phosphodiesterases
36. Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cAMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells
37. The regulation of transcription by phosphorylation
38. Epac is a Rap 1 guanine-nucleotide exchange factor directly activated by cAMP
39. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signalling pathway